11/08/2024
6:17 AM | Fulgent Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
6:10 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
3:30 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
3:30 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:20 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/05/2024
3:21 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:21 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
6:36 PM | Fulgent Genetics (Subject)
Kim Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
6:37 PM | Fulgent Genetics (Subject)
Xie Jian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
5:33 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:33 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:33 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
5:34 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
7:22 PM | Fulgent Genetics (Subject)
Hsieh Ming (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2024
6:38 AM | Fulgent Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2024
6:09 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
3:27 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
3:28 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2024
3:29 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:22 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:22 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:04 PM | Fulgent Genetics (Issuer)
Marsh Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:05 PM | Fulgent Genetics (Issuer)
GROVES REGINA E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
5:06 PM | Fulgent Genetics (Issuer)
Nohaile Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:29 PM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:21 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:22 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:34 AM | Fulgent Genetics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
6:05 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
3:35 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
6:07 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
Ming Hsieh Trust (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:26 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:27 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
3:28 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:10 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:11 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:11 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:12 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:08 AM | Fulgent Genetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad) As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential.
Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! |
02/27/2024
5:50 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:52 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:55 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
5:48 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
6:27 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
6:26 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:01 PM | Fulgent Genetics (Issuer)
Hsieh Ming (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
3:39 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:21 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:21 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:21 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
7:49 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
8:43 PM | Fulgent Genetics (Subject)
Xie Jian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2023
5:00 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:47 PM | Fulgent Genetics (Issuer)
Gao Hanlin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:54 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
5:12 PM | Fulgent Genetics (Subject)
Gao Hanlin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
5:12 PM | Fulgent Genetics (Subject)
Kim Paul (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
5:13 PM | Fulgent Genetics (Subject)
Xie Jian (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023
3:27 PM | Fulgent Genetics (Issuer)
Kim Paul (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:30 PM | Fulgent Genetics (Issuer)
Xie Jian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
